The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 5
  • 1
    Higham, Paul Grant
    Biotech Executive born in December 1962
    Individual (1 offspring)
    Officer
    2024-06-07 ~ now
    OF - Director → CIF 0
  • 2
    Nave, Christopher Dean
    Venture Capitalist born in December 1974
    Individual (2 offsprings)
    Officer
    2019-09-09 ~ now
    OF - Director → CIF 0
  • 3
    Harris, Samantha Ann
    Individual (3 offsprings)
    Officer
    2022-06-15 ~ now
    OF - Secretary → CIF 0
  • 4
    Mccarthy, Thomas David
    Company Director born in June 1967
    Individual (10 offsprings)
    Officer
    2017-02-27 ~ now
    OF - Director → CIF 0
  • 5
    Ahrens, Brenton Karl
    Venture Capital Investor born in March 1963
    Individual (3 offsprings)
    Officer
    2019-08-28 ~ now
    OF - Director → CIF 0
Ceased 6
  • 1
    Mccarthy, Kirsty Ann
    Individual (5 offsprings)
    Officer
    2017-02-27 ~ 2022-06-15
    OF - Secretary → CIF 0
  • 2
    Sidhu, Someit Singh
    Company Director born in May 1989
    Individual (13 offsprings)
    Officer
    2017-02-27 ~ 2019-08-28
    OF - Director → CIF 0
    Dr Someit Singh Sidhu
    Born in May 1989
    Individual (13 offsprings)
    Person with significant control
    2017-02-27 ~ 2018-10-29
    PE - Has significant influence or control → CIF 0
  • 3
    Guenot, Jeanmarie, Dr
    Ceo born in July 1964
    Individual
    Officer
    2022-08-26 ~ 2025-03-06
    OF - Director → CIF 0
  • 4
    Unitt, John Francis, Dr
    Director Of Bioscience born in September 1963
    Individual (1 offspring)
    Officer
    2018-11-28 ~ 2019-08-28
    OF - Director → CIF 0
  • 5
    Hughes, Stuart Wynn, Dr
    Ceo born in November 1970
    Individual (1 offspring)
    Officer
    2019-11-22 ~ 2024-06-07
    OF - Director → CIF 0
  • 6
    2765, Sand Hill Road, Menlo Park, California, United States
    Corporate
    Person with significant control
    2019-08-28 ~ 2019-08-28
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
parent relation
Company in focus

PATHIOS THERAPEUTICS LIMITED

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
82023-01-01 ~ 2023-12-31
92022-01-01 ~ 2022-12-31
Property, Plant & Equipment
42,009 GBP2023-12-31
81,624 GBP2022-12-31
Fixed Assets - Investments
85 GBP2023-12-31
Fixed Assets
42,094 GBP2023-12-31
81,624 GBP2022-12-31
Debtors
Current
1,641,512 GBP2023-12-31
2,382,969 GBP2022-12-31
Cash at bank and in hand
2,784,025 GBP2023-12-31
2,533,947 GBP2022-12-31
Current Assets
4,425,537 GBP2023-12-31
4,916,916 GBP2022-12-31
Creditors
Current, Amounts falling due within one year
-697,281 GBP2023-12-31
-807,324 GBP2022-12-31
Net Current Assets/Liabilities
3,728,256 GBP2023-12-31
4,109,592 GBP2022-12-31
Net Assets/Liabilities
3,770,350 GBP2023-12-31
4,191,216 GBP2022-12-31
Equity
Called up share capital
298 GBP2023-12-31
232 GBP2022-12-31
225 GBP2022-01-01
Share premium
25,766,682 GBP2023-12-31
20,116,540 GBP2022-12-31
20,131,530 GBP2022-01-01
Capital redemption reserve
1 GBP2023-12-31
1 GBP2022-12-31
1 GBP2022-01-01
Retained earnings (accumulated losses)
-21,996,631 GBP2023-12-31
-15,925,557 GBP2022-12-31
-9,695,117 GBP2022-01-01
Equity
3,770,350 GBP2023-12-31
4,191,216 GBP2022-12-31
10,436,639 GBP2022-01-01
Profit/Loss
Retained earnings (accumulated losses)
-6,071,074 GBP2023-01-01 ~ 2023-12-31
-6,230,440 GBP2022-01-01 ~ 2022-12-31
Profit/Loss
-6,071,074 GBP2023-01-01 ~ 2023-12-31
-6,230,440 GBP2022-01-01 ~ 2022-12-31
Comprehensive Income/Expense
Retained earnings (accumulated losses)
-6,071,074 GBP2023-01-01 ~ 2023-12-31
-6,230,440 GBP2022-01-01 ~ 2022-12-31
Comprehensive Income/Expense
-6,071,074 GBP2023-01-01 ~ 2023-12-31
-6,230,440 GBP2022-01-01 ~ 2022-12-31
Issue of Equity Instruments
Called up share capital
67 GBP2023-01-01 ~ 2023-12-31
6 GBP2022-01-01 ~ 2022-12-31
Issue of Equity Instruments
5,650,209 GBP2023-01-01 ~ 2023-12-31
-14,984 GBP2022-01-01 ~ 2022-12-31
Equity - Income/Expense Recognised Directly
Called up share capital
67 GBP2023-01-01 ~ 2023-12-31
6 GBP2022-01-01 ~ 2022-12-31
Equity - Income/Expense Recognised Directly
5,650,209 GBP2023-01-01 ~ 2023-12-31
-14,984 GBP2022-01-01 ~ 2022-12-31
Property, Plant & Equipment - Gross Cost
Office equipment
46,983 GBP2023-12-31
46,983 GBP2022-12-31
Computers
38,837 GBP2023-12-31
34,715 GBP2022-12-31
Other
77,556 GBP2023-12-31
77,556 GBP2022-12-31
Property, Plant & Equipment - Gross Cost
163,376 GBP2023-12-31
159,254 GBP2022-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Office equipment
21,799 GBP2022-12-31
Computers
22,401 GBP2022-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
77,630 GBP2022-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Office equipment, Owned/Freehold
11,746 GBP2023-01-01 ~ 2023-12-31
Computers, Owned/Freehold
12,603 GBP2023-01-01 ~ 2023-12-31
Owned/Freehold
43,737 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Office equipment
33,545 GBP2023-12-31
Computers
35,004 GBP2023-12-31
Other
52,818 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
121,367 GBP2023-12-31
Property, Plant & Equipment
Office equipment
13,438 GBP2023-12-31
25,184 GBP2022-12-31
Computers
3,833 GBP2023-12-31
12,314 GBP2022-12-31
Other
24,738 GBP2023-12-31
44,126 GBP2022-12-31
Other Debtors
Current
323,654 GBP2023-12-31
251,628 GBP2022-12-31
Prepayments/Accrued Income
Current
52,918 GBP2023-12-31
222,849 GBP2022-12-31
Amount of corporation tax that is recoverable
Current
1,264,940 GBP2023-12-31
1,908,492 GBP2022-12-31
Trade Creditors/Trade Payables
Current
486,021 GBP2023-12-31
586,869 GBP2022-12-31
Amounts owed to group undertakings
Current
85 GBP2023-12-31
Taxation/Social Security Payable
Current
93,619 GBP2023-12-31
81,489 GBP2022-12-31
Other Creditors
Current
5,219 GBP2023-12-31
1,173 GBP2022-12-31
Accrued Liabilities/Deferred Income
Current
112,337 GBP2023-12-31
137,793 GBP2022-12-31
Creditors
Current
697,281 GBP2023-12-31
807,324 GBP2022-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
513,193 shares2023-12-31
369,370 shares2022-12-31
Par Value of Share
Class 1 ordinary share
0.00012023-01-01 ~ 2023-12-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
2,465,628 shares2023-12-31
1,945,770 shares2022-12-31
Par Value of Share
Class 2 ordinary share
0.00012023-01-01 ~ 2023-12-31
Related profiles found in government register
  • PATHIOS THERAPEUTICS LIMITED
    Info
    Registered number 10641754
    99 Park Drive, Milton, Abingdon OX14 4RY
    Private Limited Company incorporated on 2017-02-27 (8 years 4 months). The company status is Active.
    The last date of confirmation statement was made at 2025-02-26
    CIF 0
  • PATHIOS THERAPEUTICS LIMITED
    S
    Registered number 10641754
    99, Park Drive, Milton, Abingdon, England, OX14 4RY
    Private Company Limited By Shares in Uk Register Of Companies, United Kingdom
    CIF 1
child relation
Offspring entities and appointments
Active 1
  • 99 Park Drive, Milton, Abingdon, England
    Active Corporate (2 parents)
    Equity (Company account)
    1 GBP2024-02-28
    Person with significant control
    2023-02-27 ~ now
    CIF 1 - Ownership of shares – 75% or more → OE
    CIF 1 - Ownership of voting rights - 75% or more → OE
    CIF 1 - Right to appoint or remove directors → OE

qrcode

Privacy notice

Terms and conditions

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.